ARIETIS CORPORATION
US UEI DCSGCN3N8D87 · SME
12public awards
$24.1Mtotal public funding
2026-07-15latest award
State aid awards (12)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-07-15 | $3.0M | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2023-09-01 | $3.0M | Grant | Development of a Dual-Targeting ClpP Activating Antibiotic | Department of Health and Human Services |
| 2021-03-08 | $3.0M | Grant | A New Approach to Treat Prosthetic Joint Infections with a ClpP Activa | Department of Health and Human Services |
| 2016-03-15 | $3.7M | Grant | Bactericidal antibiotic for Vancomycin Resistant Enterococci | Department of Health and Human Services |
| 2015-05-01 | $3.0M | Grant | Antibiotics for Recalcitrant Infection | Department of Health and Human Services |
| 2014-01-01 | $300k | Grant | Antibiotics for Recalcitrant Infection | Department of Health and Human Services |
| 2013-07-01 | $3.0M | Grant | Narrow-spectrum Agents Acting against Helicobacter pylori | Department of Health and Human Services |
| 2012-01-01 | $297k | Grant | Narrow-spectrum Agents Acting against Helicobacter pylori | Department of Health and Human Services |
| 2012-01-01 | $586k | Grant | Compounds to treat Helicobacter pylori infection | Department of Health and Human Services |
| 2010-01-01 | $3.0M | Grant | Therapy Against Recalcitrant C. albicans Infection | Department of Health and Human Services |
| 2010-01-01 | $598k | Grant | 2-adamantanamine Based Therapeutic for Recurrent Oropharyngeal Candidi | Department of Health and Human Services |
| 2008-01-01 | $599k | Grant | THERAPY AGAINST RECALCITRANT C. albicans INFECTION | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →